LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer

Triple negative breast cancer (TNBC) is an aggressive type of breast cancer with high heterogeneity. To date, there is no efficient therapy for TNBC patients and the prognosis is poor. It is urgent to find new biomarkers for the diagnosis of TNBC or efficient therapy targets. As an area of focus in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Mingming, Xu, Pengfei, Wu, Ying, Huang, Lei, Li, Wenqu, Lv, Shanshan, Wu, Xiaowei, Zeng, Xin, Shen, Rong, Jia, Xuemei, Yin, Yongmei, Gu, Yun, Yuan, Hongyan, Xie, Hui, Fu, Ziyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914340/
https://www.ncbi.nlm.nih.gov/pubmed/26910840
http://dx.doi.org/10.18632/oncotarget.7509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914340/
https://www.ncbi.nlm.nih.gov/pubmed/26910840
http://dx.doi.org/10.18632/oncotarget.7509

Ejemplares similares